½ÃÀ庸°í¼­
»óǰÄÚµå
1578910

¼¼°èÀÇ SPR ºÐÀÚ°£ »óÈ£ÀÛ¿ë ºÐ¼®±â ½ÃÀå : Á¦Ç° À¯Çüº°, ¿ëµµº°, ÃÖÁ¾ »ç¿ëÀÚº°, ±â¼úº°-¿¹Ãø(2025-2030³â)

SPR Molecular Interaction Analyzer Market by Product Type (Bio-Sensors, Reagents, Software & Services), Application (Agriculture & Food, Biomolecular Interactions, Clinical Diagnostics), End-User, Technology - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 180 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

SPR ºÐÀÚ°£ »óÈ£ÀÛ¿ë ºÐ¼®±â ½ÃÀåÀº 2023³â 12¾ï 8,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾úÀ¸¸ç, 2024³â¿¡´Â 13¾ï 5,000¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¸ç, CAGR 5.55%·Î ¼ºÀåÇÒ Àü¸ÁÀ̰í, 2030³â¿¡´Â 18¾ï 7,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

SPR ºÐÀÚ°£ »óÈ£ÀÛ¿ë ºÐ¼®±â ½ÃÀåÀº Ç¥¸é ÇöóÁî¸ó °ø¸í ±â¼úÀ» ÀÌ¿ëÇÑ »ýüºÐÀÚ°£ »óÈ£ÀÛ¿ëÀÇ ºÐ¼®¿¡ À־ÀÇ ¿ªÇÒ¿¡ ÀÇÇØ Á¤Àǵ˴ϴÙ. SPRÀÇ Çʿ伺Àº »ýüºÐÀÚ »óÈ£ÀÛ¿ëÀÇ Á¤È®ÇÑ ÃøÁ¤°ú ºÐ¼®ÀÌ °¡Àå Áß¿äÇÑ Ã¢¾à, »ý¸í°úÇÐ, »ýÈ­ÇÐ, Áø´ÜÇп¡ ´ëÇÑ ¿ëµµ·ÎºÎÅÍ ¹ß»ýÇÕ´Ï´Ù. ÀÌ ±â¼úÀº »ýü ºÐÀÚÀÇ °áÇÕ ¼Óµµ, Ä£ È­¼º ¹× ³óµµ¸¦ ÀÌÇØÇÏ´Â µ¥ ÇʼöÀûÀ̸ç Á¦¾à ȸ»ç, ¿¬±¸ ±â°ü ¹× Áø´Ü ½ÇÇè½Ç¿¡ Å« À¯¿ë¼ºÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ½ÃÀåÀº »ý¸í °øÇÐÀÇ ÁøÀü°ú ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ÀÇÇØ Áö¿øµÇ°í ÀÖ½À´Ï´Ù. ÁÖ¿ä ¼ºÀå ¿äÀÎÀ¸·Î´Â °í±Þ Áø´Ü µµ±¸°¡ ÇÊ¿äÇÑ ¸¸¼º ÁúȯÀÇ À¯º´·ü »ó½Â, °¨µµ ¹× ƯÀ̼º Çâ»óÀ» Á¦°øÇÏ´Â ±â¼úÀÇ Áøº¸, »ý¸í °úÇÐ ¿¬±¸¿¡ ´ëÇÑ ÀÚ±Ý Á¦°ø Áõ°¡ µîÀÌ ÀÖ½À´Ï´Ù. ¶ÇÇÑ COVID-19¿Í °°Àº ´ë±Ô¸ð ¹é½Å ¹× Ä¡·á¹ýÀÇ °³¹ßÀº SPR ±â¼úÀÇ À¯¿ë¼ºÀ» º¸¿© ÁÖ¸ç °ü·Ã ¹ÙÀÌ¿À¼¾¼­ ¿ëµµÀ» È®´ëÇÒ ±âȸ¸¦ Á¦½ÃÇÕ´Ï´Ù. ±×·¯³ª ÀåÄ¡ÀÇ °íºñ¿ë, µ¥ÀÌÅÍ ºÐ¼®ÀÇ º¹À⼺, ¼÷·ÃµÈ Àü¹®°¡ ºÎÁ· µîÀÇ °úÁ¦´Â ½ÃÀå ¼ºÀåÀ» ¹æÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¾ö°ÝÇÑ ±ÔÁ¦ ȯ°æ, µî¿Â ÀûÁ¤ Ä®·Î¸®¸ÞÆ®¸® ¹× »ýüÃþ °£¼·¹ý°ú °°Àº ´ëü ºÐ¼® ±â¼ú°úÀÇ °æÀïÀÌ ÀáÀçÀûÀÎ À§ÇùÀÌ µË´Ï´Ù. ±â¼úÇõ½ÅÀÇ ±âȸ´Â ÈÞ´ë¿ëÀÌ°í ºñ¿ë È¿À²ÀûÀÎ Àåºñ °³¹ß, µ¥ÀÌÅÍ ºÐ¼® Çâ»óÀ» À§ÇÑ AI ÅëÇÕ, º¸´Ù ±¤¹üÀ§ÇÑ ¿ëµµ¸¦ À§ÇÑ ¸ÖƼÇ÷º½Ì ±â´ÉÀ» °­È­ÇÏ´Â °ÍÀÔ´Ï´Ù. ºñÁî´Ï½º ¼ºÀåÀ» À§Çؼ­´Â ±â¾÷Àº ½ÅÈï ½ÃÀå¿¡ ÁøÃâÇÏ°í ´Ù¾çÇÑ ¿ëµµ¿¡ ¸Â°Ô ¼Ö·ç¼ÇÀ» ¸ÂÃãÈ­Çϱâ À§ÇÑ ¿¬±¸°³¹ß¿¡ ´ëÇÑ ÅõÀÚ¿¡ ÁÖ·ÂÇØ¾ß ÇÕ´Ï´Ù. Çмú¿¬±¸±â°ü°úÀÇ Àü·«Àû ÆÄÆ®³Ê½ÊÀº Çõ½ÅÀûÀÎ ¹ßÀü°ú ½ÃÀå ħÅõ¸¦ ÃËÁøÇÏ´Â °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ½ÃÀåÀÇ ¼º°ÝÀº ÅëÇÕÀ» ±â¿ïÀ̰í ÀÖÀ¸¸ç ´ë±â¾÷Àº ±â¼ú Æ÷Æ®Æú¸®¿À¿Í ½ÃÀå µµ´Þ¹üÀ§¸¦ °­È­Çϱâ À§ÇØ M&A¿¡ ÅõÀÚÇϰí Àִµ¥, ÀÌ´Â Áö¼ÓÀûÀÎ Çõ½Å°ú Àü·«Àû ¼±°ß¼ºÀ» ÅëÇØ °æÀï·Â À¯ÁöÀÇ Á߿伺À» °­Á¶Çϰí ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ(2023) 12¾ï 8,000¸¸ ´Þ·¯
¿¹Ãø³â(2024) 13¾ï 5,000¸¸ ´Þ·¯
¿¹Ãø³â(2030) 18¾ï 7,000¸¸ ´Þ·¯
CAGR(%) 5.55%

½ÃÀå ¿ªÇÐ : ºü¸£°Ô ÁøÈ­ÇÏ´Â SPR ºÐÀÚ°£ »óÈ£ÀÛ¿ë ºÐ¼®±â ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

SPR ºÐÀÚ°£ »óÈ£ÀÛ¿ë ºÐ¼®±â ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯¸ðÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ ÁøÈ­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÅõÀÚ°áÁ¤, Àü·«Àû ÀÇ»ç°áÁ¤, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ ȹµæÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ À§ÇèÀ» ¿ÏÈ­ÇÒ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë°ú ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ»º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ³ôÀº °¨µµ¿Í ƯÀ̼º¿¡ ÀÇÇÑ, â¾à ¹× ¾àÁ¦ °³¹ß¿¡ À־ÀÇ SPR ±â¼úÀÇ Ã¤¿ë Áõ°¡
    • »ý¸í°úÇÐ ¿¬±¸¿¡¼­ ¶óº§ ÇÁ¸® °ËÃâ¹ýÀÇ ÀÌ¿ë È®´ë¿¡ ÀÇÇÑ Á¤¹Ðµµ¿Í È¿À²ÀÇ Çâ»ó
    • ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ºÐ¾ß¿¡¼­ÀÇ ÀÚ±Ý Á¶´Þ°ú ÅõÀÚ Áõ°¡¿¡ ÀÇÇÑ Ã·´Ü ºÐ¼®±â ¼ö¿ä Áõ°¡
    • ¼¾¼­ ±â¼úÀÇ Áøº¸°¡ SPR ºÐÀÚ°£ »óÈ£ÀÛ¿ë ºÐ¼®±âÀÇ ¼º´É°ú ¿ëµµ °­È­
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±â¼úÀÇ º¹À⼺°ú ¼÷·ÃÀÚÀÇ Çʿ伺
  • ½ÃÀå ±âȸ
    • ¸ÂÃãÇü ÀÇ·á ½ÃÀå¿¡¼­ÀÇ SPR ºÐÀÚ°£ »óÈ£ÀÛ¿ë ºÐ¼®±â ¿ëµµ È®´ë
    • â¾à ¹× ¾àÁ¦ °³¹ß ÇÁ·Î¼¼½º¿¡ À־ÀÇ SPR ºÐÀÚ°£ »óÈ£ÀÛ¿ë ºÐ¼®±â ¼ö¿ä Áõ°¡
    • ¹ÙÀÌ¿ÀÀǾàǰ ¿¬±¸ ºÐ¾ß¿¡¼­ÀÇ SPR ºÐÀÚ°£ »óÈ£ÀÛ¿ë ºÐ¼®±â ä¿ë Áõ°¡
  • ½ÃÀåÀÇ °úÁ¦
    • ´ëü ±â¼ú°úÀÇ °æÀï

Porter's Five Forces : SPR ºÐÀÚ°£ »óÈ£ÀÛ¿ë ºÐ¼®±â ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Forces ÇÁ·¹ÀÓ ¿öÅ©´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Forces ÇÁ·¹ÀÓ ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ ޱ¸ÇÏ´Â ¸íÈ®ÇÑ ±â¼úÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» °áÁ¤ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®¸¦ ÅëÇØ ±â¾÷Àº ÀÚ»çÀÇ °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ °úÁ¦¸¦ ÇÇÇÒ ¼ö ÀÖÀ¸¸ç, º¸´Ù °­ÀÎÇÑ ½ÃÀå¿¡¼­ÀÇ Æ÷Áö¼Å´×À» º¸ÀåÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : SPR ºÐÀÚ°£ »óÈ£ÀÛ¿ë ºÐ¼®±â ½ÃÀå¿¡¼­ ¿ÜºÎ·ÎºÎÅÍÀÇ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ãȯ°æ ¿äÀÎÀº SPR ºÐÀÚ°£ »óÈ£ÀÛ¿ë ºÐ¼®±â ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇϴµ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀÎ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¾ÕÀ¸·Î ¿¹»óµÇ´Â Àû±ØÀûÀÎ ÀÇ»ç °áÁ¤À» ÇÒ Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : SPR ºÐÀÚ°£ »óÈ£ÀÛ¿ë ºÐ¼®±â ½ÃÀå¿¡¼­ °æÀï ±¸µµ ÆÄ¾Ç

SPR ºÐÀÚ°£ »óÈ£ÀÛ¿ë ºÐ¼®±â ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü µî ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀï Æ÷Áö¼Å´×À» ¹àÈú ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ½ÃÀå ÁýÁß, ´ÜÆíÈ­ ¹× ÅëÇÕ µ¿ÇâÀ» ¹àÇô³»°í °ø±Þ¾÷ü´Â °æÀïÀÌ Ä¡¿­ÇØÁö¸é¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç °áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ Áö½ÄÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : SPR ºÐÀÚ°£ »óÈ£ÀÛ¿ë ºÐ¼®±â ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â SPR ºÐÀÚ°£ »óÈ£ÀÛ¿ë ºÐ¼®±â ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ Çà·ÄÀ» ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº °ø±Þ¾÷üÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±âÁØÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ¸Â´Â ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ³× °¡Áö »çºÐ¸éÀ» ÅëÇØ °ø±Þ¾÷ü¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ºÎ¹®È­Çϰí Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ : SPR ºÐÀÚ°£ »óÈ£ÀÛ¿ë ºÐ¼®±â ½ÃÀå¿¡¼­ ¼º°øÀ» À§ÇÑ ±æ ±×¸®±â

SPR ºÐÀÚ°£ »óÈ£ÀÛ¿ë ºÐ¼®±â ½ÃÀåÀÇ Àü·«ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ÀÇ ÇÁ·¹Á𽺠°­È­¸¦ ¸ñÇ¥·Î ÇÏ´Â ±â¾÷¿¡ ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ´É·Â ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í °³¼±À» À§ÇØ ³ë·ÂÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ üÁ¦¸¦ ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀåÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·ÂÀ» Æò°¡ÇÕ´Ï´Ù.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡ÇÏ¸ç ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, ¿¬±¸°³¹ß Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾ò°í ÀÇ»ç°áÁ¤À» ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ë´äÇϰí ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð ¹× ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ ¹× ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À² ¹× °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ³ôÀº °¨µµ¿Í ƯÀ̼ºÀ¸·Î SPR ±â¼úÀº ÀǾàǰÀÇ ¹ß°ß°ú °³¹ß¿¡ äÅõǰí ÀÖ½À´Ï´Ù.
      • »ý¸í°úÇÐ ¿¬±¸¿¡ À־ÀÇ Á¤¹Ðµµ¿Í È¿À²¼ºÀÇ Çâ»óÀ» ¸ñÀûÀ¸·Î ÇÑ ¶óº§ ÇÁ¸® °ËÃâ¹ýÀÇ ÀÌ¿ë Áõ°¡
      • ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ºÐ¾ß¿¡ÀÇ Àڱݰú ÅõÀÚ Áõ°¡°¡ ÷´Ü ºÐ¼®±â ¼ö¿ä °ßÀÎ
      • SPR ºÐÀÚ°£ »óÈ£ÀÛ¿ë ºÐ¼®±âÀÇ ¼º´É°ú ¿ëµµ °­È­ ¼¾¼­ ±â¼ú ¹ßÀü
    • ¾ïÁ¦¿äÀÎ
      • ±â¼úÀûÀÎ º¹À⼺°ú ¼÷·ÃµÈ ÀÎÀçÀÇ Çʿ伺
    • ±âȸ
      • ¸ÂÃãÇü ÀÇ·á ½ÃÀå¿¡¼­ SPR ºÐÀÚ°£ »óÈ£ÀÛ¿ë ºÐ¼®±âÀÇ ¿ëµµ È®´ë
      • ÀǾàǰÀÇ ¹ß°ß°ú °³¹ß °úÁ¤¿¡¼­ÀÇ SPR ºÐÀÚ°£ »óÈ£ÀÛ¿ë ºÐ¼®±â ¼ö¿ä Áõ°¡
      • ¹ÙÀÌ¿À ÀǾàǰ Á¶»ç ºÐ¾ß¿¡ À־ÀÇ SPR ºÐÀÚ°£ »óÈ£ÀÛ¿ë ºÐ¼®±âÀÇ Ã¤¿ë Áõ°¡
    • °úÁ¦
      • ´ëü ±â¼ú°úÀÇ °æÀï
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦
    • »ç±³
    • ±â¼úÀû
    • ¹ý·ü»ó
    • ȯ°æ

Á¦6Àå SPR ºÐÀÚ°£ »óÈ£ÀÛ¿ë ºÐ¼®±â ½ÃÀå : Á¦Ç° À¯Çüº°

  • ¹ÙÀÌ¿À¼¾¼­
  • ½Ã¾à
    • DNA ¹× RNA ½Ã¾à
    • ¸®°£µå °áÇÕ ºÐ¼®
    • ´Ü¹éÁú ½Ã¾à
  • ¼ÒÇÁÆ®¿þ¾î ¹× ¼­ºñ½º
    • µ¥ÀÌÅÍ ºÐ¼® ¼ÒÇÁÆ®¿þ¾î
    • Å×Å©´ÏÄà ¼­Æ÷Æ® ¼­ºñ½º
  • SPR ½Ã½ºÅÛ
    • º¥Ä¡Å¾ ½Ã½ºÅÛ
    • ÈÞ´ë¿ë ½Ã½ºÅÛ

Á¦7Àå SPR ºÐÀÚ°£ »óÈ£ÀÛ¿ë ºÐ¼®±â ½ÃÀå : ¿ëµµº°

  • ³ó¾÷ ¹× ½Äǰ
    • º´¿øÃ¼ °ËÃâ
    • ǰÁú°ü¸®
  • »ýüºÐÀÚ »óÈ£ÀÛ¿ë
    • DNA-´Ü¹éÁú »óÈ£ÀÛ¿ë
    • ¾à¹°°ú ´Ü¹éÁúÀÇ »óÈ£ÀÛ¿ë
    • ´Ü¹éÁú°£ »óÈ£ÀÛ¿ë
  • ÀÓ»ó Áø´Ü
    • Áúº´ ¹ÙÀÌ¿À¸¶Ä¿ °ËÃâ
    • º´¿øÃ¼ÀÇ Æ¯Á¤
  • â¾à
    • ¾î¼¼ÀÌ °³¹ß
    • ¸®µå »ý¼º ¹× ÃÖÀûÈ­
    • Ÿ°Ù ½Äº°
  • ȯ°æ ¸ð´ÏÅ͸µ
    • ¿À¿°¹°Áú °ËÃâ
    • ¼öÁú Æò°¡

Á¦8Àå SPR ºÐÀÚ°£ »óÈ£ÀÛ¿ë ºÐ¼®±â ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • Çмú¿¬±¸±â°ü
    • ±âÃÊÁ¶»ç
    • °øµ¿Á¶»ç
  • °è¾à¿¬±¸±â°ü
  • ȯ°æ½ÃÇ迬±¸¼Ò
  • º´¿ø ¹× Ŭ¸®´Ð
  • Á¦¾à ¹× ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷
    • Á¦Á¶¾÷
    • ǰÁú º¸Áõ ¹× °ü¸®
    • ¿¬±¸°³¹ß

Á¦9Àå SPR ºÐÀÚ°£ »óÈ£ÀÛ¿ë ºÐ¼®±â ½ÃÀå : ±â¼úº°

  • ±¹¼Ò Ç¥¸é ÇöóÁî¸ó °ø¸í(LSPR)
    • °¨µµ Çâ»ó
    • ´ÙÁßÈ­ ±â´É
  • Ç¥¸é ÇöóÁî¸ó °ø¸í(SPR)
    • ¶óº§ ÇÁ¸® °ËÃâ
    • ½Ç½Ã°£ °¨½Ã

Á¦10Àå ¾Æ¸Þ¸®Ä«ÀÇ SPR ºÐÀÚ°£ »óÈ£ÀÛ¿ë ºÐ¼®±â ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦11Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ SPR ºÐÀÚ°£ »óÈ£ÀÛ¿ë ºÐ¼®±â ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦12Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ SPR ºÐÀÚ°£ »óÈ£ÀÛ¿ë ºÐ¼®±â ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦13Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®(2023³â)
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º(2023³â)
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼® ¹× Á¦¾È

±â¾÷ ¸ñ·Ï

  • Adam Equipment Co., Ltd.
  • Affymetrix, Inc.
  • Bio-Rad Laboratories, Inc.
  • BiOptix Diagnostics, Inc.
  • CTS Corporation
  • Endress Hauser Group Services AG
  • General Electric Company
  • Hanna Instruments, Inc.
  • Horiba, Ltd.
  • Malvern Panalytical Ltd
  • Mettler-Toledo International Inc.
  • Nihon Dempa Kogyo Co., Ltd.
  • PerkinElmer, Inc.
  • Plexera Bioscience LLC
  • Shimadzu Corporation
  • Tami Group
  • Tempcon Instrumentation Ltd
  • Waters Corporation
  • Xenotronics Company
  • Xtal Concept GmbH
AJY 24.11.04

The SPR Molecular Interaction Analyzer Market was valued at USD 1.28 billion in 2023, expected to reach USD 1.35 billion in 2024, and is projected to grow at a CAGR of 5.55%, to USD 1.87 billion by 2030.

The SPR Molecular Interaction Analyzer market is defined by its role in analyzing biomolecular interactions using Surface Plasmon Resonance technology, a crucial tool for real-time, label-free interaction analysis. The necessity of SPR arises from its application in drug discovery, life sciences, biochemistry, and diagnostics, where precise measurement and analysis of biomolecular interactions are paramount. The technology is vital in understanding binding kinetics, affinity, and concentration of biomolecules, offering significant utility for pharmaceutical companies, research institutions, and diagnostic laboratories. The market is bolstered by ongoing advancements in biotechnology and increasing demand for personalized medicine. Key growth factors include the rising prevalence of chronic diseases necessitating advanced diagnostic tools, technological advancements offering enhanced sensitivity and specificity, and increased funding for life sciences research. Additionally, large-scale vaccine and therapeutic development, such as COVID-19, have showcased the utility of SPR technologies, presenting opportunities for expansion in relevant biosensor applications. However, challenges such as high costs of instruments, complexity in data interpretation, and limited availability of skilled professionals could hinder market growth. Furthermore, stringent regulatory environments and competition from alternative analytical techniques like isothermal titration calorimetry or bio-layer interferometry pose potential threats. Innovation opportunities lie in developing portable, cost-effective devices, integrating AI for improved data analytics, and enhancing multiplexing capabilities for broader applications. For business growth, companies should focus on expanding into emerging markets and investing in R&D to customize solutions for diverse applications. Strategic partnerships with academic and research institutions could facilitate innovative advancements and market penetration. The market's nature leans towards consolidation, with major players investing in mergers and acquisitions to bolster their technological portfolio and market reach, underscoring the importance of staying competitive through continuous innovation and strategic foresight.

KEY MARKET STATISTICS
Base Year [2023] USD 1.28 billion
Estimated Year [2024] USD 1.35 billion
Forecast Year [2030] USD 1.87 billion
CAGR (%) 5.55%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving SPR Molecular Interaction Analyzer Market

The SPR Molecular Interaction Analyzer Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increased adoption of SPR technology in drug discovery and development due to its high sensitivity and specificity
    • Growing utilization of label-free detection methods in life sciences research to improve accuracy and efficiency
    • Rise in funding and investments in the biotechnology sector driving the demand for advanced analyzers
    • Advancements in sensor technology enhancing the performance and applications of SPR molecular interaction analyzers
  • Market Restraints
    • Technical complexity and need for skilled personnel
  • Market Opportunities
    • Expanding applications of SPR molecular interaction analyzers in personalized medicine market
    • Growing demand for SPR molecular interaction analyzers in drug discovery and development processes
    • Increasing adoption of SPR molecular interaction analyzers in the field of biopharmaceutical research
  • Market Challenges
    • Competition from alternative technologies

Porter's Five Forces: A Strategic Tool for Navigating the SPR Molecular Interaction Analyzer Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the SPR Molecular Interaction Analyzer Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the SPR Molecular Interaction Analyzer Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the SPR Molecular Interaction Analyzer Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the SPR Molecular Interaction Analyzer Market

A detailed market share analysis in the SPR Molecular Interaction Analyzer Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the SPR Molecular Interaction Analyzer Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the SPR Molecular Interaction Analyzer Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the SPR Molecular Interaction Analyzer Market

A strategic analysis of the SPR Molecular Interaction Analyzer Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the SPR Molecular Interaction Analyzer Market, highlighting leading vendors and their innovative profiles. These include Adam Equipment Co., Ltd., Affymetrix, Inc., Bio-Rad Laboratories, Inc., BiOptix Diagnostics, Inc., CTS Corporation, Endress+Hauser Group Services AG, General Electric Company, Hanna Instruments, Inc., Horiba, Ltd., Malvern Panalytical Ltd, Mettler-Toledo International Inc., Nihon Dempa Kogyo Co., Ltd., PerkinElmer, Inc., Plexera Bioscience LLC, Shimadzu Corporation, Tami Group, Tempcon Instrumentation Ltd, Waters Corporation, Xenotronics Company, and Xtal Concept GmbH.

Market Segmentation & Coverage

This research report categorizes the SPR Molecular Interaction Analyzer Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Bio-Sensors, Reagents, Software & Services, and SPR Systems. The Reagents is further studied across DNA & RNA Reagents, Ligand Binding Assays, and Protein Reagents. The Software & Services is further studied across Data Analysis Software and Technical Support Services. The SPR Systems is further studied across Benchtop Systems and Portable Systems.
  • Based on Application, market is studied across Agriculture & Food, Biomolecular Interactions, Clinical Diagnostics, Drug Discovery, and Environmental Monitoring. The Agriculture & Food is further studied across Pathogen Detection and Quality Control. The Biomolecular Interactions is further studied across DNA-Protein Interactions, Drug-Protein Interactions, and Protein-Protein Interactions. The Clinical Diagnostics is further studied across Disease Biomarker Detection and Pathogen Identification. The Drug Discovery is further studied across Assay Development, Lead Generation & Optimization, and Target Identification. The Environmental Monitoring is further studied across Pollutant Detection and Water Quality Assessment.
  • Based on End-User, market is studied across Academic & Research Institutes, Contract Research Organizations, Environmental Testing Laboratories, Hospitals & Clinics, and Pharmaceutical & Biotechnology Companies. The Academic & Research Institutes is further studied across Basic Research and Collaborative Research. The Pharmaceutical & Biotechnology Companies is further studied across Manufacturing, Quality Assurance & Control, and Research & Development.
  • Based on Technology, market is studied across Localized Surface Plasmon Resonance (LSPR) and Surface Plasmon Resonance (SPR). The Localized Surface Plasmon Resonance (LSPR) is further studied across Enhanced Sensitivity and Multiplexing Capability. The Surface Plasmon Resonance (SPR) is further studied across Label-Free Detection and Real-Time Monitoring.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increased adoption of SPR technology in drug discovery and development due to its high sensitivity and specificity
      • 5.1.1.2. Growing utilization of label-free detection methods in life sciences research to improve accuracy and efficiency
      • 5.1.1.3. Rise in funding and investments in the biotechnology sector driving the demand for advanced analyzers
      • 5.1.1.4. Advancements in sensor technology enhancing the performance and applications of SPR molecular interaction analyzers
    • 5.1.2. Restraints
      • 5.1.2.1. Technical complexity and need for skilled personnel
    • 5.1.3. Opportunities
      • 5.1.3.1. Expanding applications of SPR molecular interaction analyzers in personalized medicine market
      • 5.1.3.2. Growing demand for SPR molecular interaction analyzers in drug discovery and development processes
      • 5.1.3.3. Increasing adoption of SPR molecular interaction analyzers in the field of biopharmaceutical research
    • 5.1.4. Challenges
      • 5.1.4.1. Competition from alternative technologies
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. SPR Molecular Interaction Analyzer Market, by Product Type

  • 6.1. Introduction
  • 6.2. Bio-Sensors
  • 6.3. Reagents
    • 6.3.1. DNA & RNA Reagents
    • 6.3.2. Ligand Binding Assays
    • 6.3.3. Protein Reagents
  • 6.4. Software & Services
    • 6.4.1. Data Analysis Software
    • 6.4.2. Technical Support Services
  • 6.5. SPR Systems
    • 6.5.1. Benchtop Systems
    • 6.5.2. Portable Systems

7. SPR Molecular Interaction Analyzer Market, by Application

  • 7.1. Introduction
  • 7.2. Agriculture & Food
    • 7.2.1. Pathogen Detection
    • 7.2.2. Quality Control
  • 7.3. Biomolecular Interactions
    • 7.3.1. DNA-Protein Interactions
    • 7.3.2. Drug-Protein Interactions
    • 7.3.3. Protein-Protein Interactions
  • 7.4. Clinical Diagnostics
    • 7.4.1. Disease Biomarker Detection
    • 7.4.2. Pathogen Identification
  • 7.5. Drug Discovery
    • 7.5.1. Assay Development
    • 7.5.2. Lead Generation & Optimization
    • 7.5.3. Target Identification
  • 7.6. Environmental Monitoring
    • 7.6.1. Pollutant Detection
    • 7.6.2. Water Quality Assessment

8. SPR Molecular Interaction Analyzer Market, by End-User

  • 8.1. Introduction
  • 8.2. Academic & Research Institutes
    • 8.2.1. Basic Research
    • 8.2.2. Collaborative Research
  • 8.3. Contract Research Organizations
  • 8.4. Environmental Testing Laboratories
  • 8.5. Hospitals & Clinics
  • 8.6. Pharmaceutical & Biotechnology Companies
    • 8.6.1. Manufacturing
    • 8.6.2. Quality Assurance & Control
    • 8.6.3. Research & Development

9. SPR Molecular Interaction Analyzer Market, by Technology

  • 9.1. Introduction
  • 9.2. Localized Surface Plasmon Resonance (LSPR)
    • 9.2.1. Enhanced Sensitivity
    • 9.2.2. Multiplexing Capability
  • 9.3. Surface Plasmon Resonance (SPR)
    • 9.3.1. Label-Free Detection
    • 9.3.2. Real-Time Monitoring

10. Americas SPR Molecular Interaction Analyzer Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific SPR Molecular Interaction Analyzer Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa SPR Molecular Interaction Analyzer Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Adam Equipment Co., Ltd.
  • 2. Affymetrix, Inc.
  • 3. Bio-Rad Laboratories, Inc.
  • 4. BiOptix Diagnostics, Inc.
  • 5. CTS Corporation
  • 6. Endress+Hauser Group Services AG
  • 7. General Electric Company
  • 8. Hanna Instruments, Inc.
  • 9. Horiba, Ltd.
  • 10. Malvern Panalytical Ltd
  • 11. Mettler-Toledo International Inc.
  • 12. Nihon Dempa Kogyo Co., Ltd.
  • 13. PerkinElmer, Inc.
  • 14. Plexera Bioscience LLC
  • 15. Shimadzu Corporation
  • 16. Tami Group
  • 17. Tempcon Instrumentation Ltd
  • 18. Waters Corporation
  • 19. Xenotronics Company
  • 20. Xtal Concept GmbH
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦